PHILADELPHIA — (Tuesday, April 30, 2024) — Hepatocellular carcinoma (HCC), or liver cancer, is an aggressive malignancy with limited treatment options. An immunologically cold cancer — meaning the tu…
PHILADELPHIA — (April 10, 2024) — The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that m…
PHILADELPHIA—(Mar. 28, 2024)— The Wistar Institute’s Qing Chen, M.D., Ph.D., assistant professor in the Immunology, Microenvironment and Metastasis Program at the Ellen and Ronald Caplan Cancer Cente…
Marking the next step in their innovative academic collaboration, Philadelphia College of Osteopathic Medicine (PCOM) and The Wistar Institute have announced the launch of a highly anticipated Cancer…
PHILADELPHIA — (Feb 27, 2024) — The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Max Berger to its Board of Trustees.&n…
PHILADELPHIA—(Feb. 21, 2024)—The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., has demonstrated, with his lab and collaborators, a connection between viral damage to the gut and…
Wistar scientist joins faculty to pursue research in breast and brain cancers PHILADELPHIA—(Feb. 13, 2024)— The Wistar Institute, an international biomedical research leader in cancer, infectious dis…
PHILADELPHIA (January 17, 2024) – The West Philadelphia Skills Initiative and The Wistar Institute are collaborating once again with support from the Philadelphia Industrial Development Corporation a…
PHILADELPHIA—(Dec. 18, 2023)—The Wistar Institute, a global leader in biomedical research in cancer, immunology and infectious disease, is pleased to welcome Aleister Saunders, Ph.D., and Patrick Oat…
PHILADELPHIA—(Dec. 13, 2023)— The Wistar Institute, an international biomedical research leader in cancer, infectious disease, immunology, and vaccine development, is pleased to announce the recruitm…
